Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Moschini M, Necchi A, Montorsi F. Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Eur Urol 2024 Feb 17:S0302-2838(24)00068-X. doi: 10.1016/j.eururo.2023.
PMID: 38369421


Privacy Policy